The cyclin-G associated kinase (GAK) is a novel mitotic kinase and therapeutic target in diffuse large B-cell lymphoma
Olivia Barbara Farag, Bassel Awada, Abdessamad Youssfi Alaoui, Paola Manara, Anna Kingham, Preet Kumar, Lingxiao Li, Brian B. Silver, Toral Shastri, Santiago Vilar, Austin D. Newsam, Marianna Lekakis, Diego E. Hernandez Parets, Pierre A. Younes, Dhanvantri Chahar, , Jonathan Harry Schatz
This paper identifies GAK as a novel mitotic kinase and therapeutic target in DLBCL, showing that GAK inhibition causes mitotic defects and that existing drugs can be repurposed for its targeting.
Leukemia · Nov 2, 2026Peer-reviewedCancer Biology